Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Safusidenib by Nuvation Bio for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Safusidenib is under clinical development by Nuvation Bio and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According to...
Safusidenib by AnHeart Therapeutics for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Safusidenib is under clinical development by AnHeart Therapeutics and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According to...
Safusidenib by AnHeart Therapeutics for Solid Tumor: Likelihood of Approval
Safusidenib is under clinical development by AnHeart Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...